Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
10.98
+0.28 (2.62%)
Feb 21, 2025, 4:00 PM EST - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $70.20 million as of February 21, 2025. Its market cap has increased by 227.34% in one year.
Market Cap
70.20M
Enterprise Value
53.84M
1-Year Change
227.34%
Ranking
Category
Stock Price
$10.98
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has decreased from $181.43M to $70.20M, a decrease of -61.31%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 70.20M | -51.65% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | 467.16M | 157.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |